Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

V. Saraswat; S. Norris; R. J. De Knegt; J. F. Sanchez Avila; M. Sonderup; E. Zuckerman; P. Arkkila; C. Stedman; S. Acharya; I. Aho; A. C. Anand; M. I. Andersson; V. Arendt; O. Baatarkhuu; K. Barclay; Z. Ben-Ari; C. Bergin; F. Bessone; S. Blach; N. Blokhina; C. R. Brunton; G. Choudhuri; V. Chulanov; L. Cisneros; E. A. Croes; Y. A. Dahgwahdorj; O. Dalgard; J. R. Daruich; N. R. Dashdorj; D. Davaadorj; M. De Vree; C. Estes; R. Flisiak; A. C. Gadano; E. Gane; W. Halota; A. Hatzakis; C. Henderson; P. Hoffmann; J. Hornell; D. Houlihan; S. Hrusovsky; P. Jarčuška; D. Kershenobich; K. Kostrzewska; P. Kristian; M. Leshno; Y. Lurie; A. Mahomed; N. Mamonova; N. Mendez-Sanchez; J. Mossong; E. Nurmukhametova; P. Nymadawa; M. Oltman; J. Oyunbileg; Ts Oyunsuren; G. Papatheodoridis; N. Pimenov; N. Prabdial-Sing; M. Prins; P. Puri; S. Radke; A. Rakhmanova; H. Razavi; K. Razavi-Shearer; H. W. Reesink; E. Ridruejo; R. Safadi; O. Sagalova; R. Sanduijav; I. Schréter; C. Seguin-Devaux; S. R. Shah; I. Shestakova; A. Shevaldin; O. Shibolet; S. Sokolov; K. Souliotis; C. W. Spearman; T. Staub; E. A. Strebkova; D. Struck; K. Tomasiewicz; L. Undram; A. J. Van Der Meer; D. Van Santen; I. Veldhuijzen; F. G. Villamil; S. Willemse; F. R. Zuure; M. O. Silva; V. Sypsa; E. Gower

doi:10.1111/jvh.12350

Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

V. Saraswat^*
, S. Norris
, R. J. De Knegt
, J. F. Sanchez Avila
, M. Sonderup
, E. Zuckerman
, P. Arkkila
, C. Stedman
, S. Acharya
, I. Aho
, A. C. Anand
, M. I. Andersson
, V. Arendt
, O. Baatarkhuu
, K. Barclay
, Z. Ben-Ari
, C. Bergin
, F. Bessone
, S. Blach
, N. Blokhina

C. R. Brunton, G. Choudhuri, V. Chulanov, L. Cisneros, E. A. Croes, Y. A. Dahgwahdorj, O. Dalgard, J. R. Daruich, N. R. Dashdorj, D. Davaadorj, M. De Vree, C. Estes, R. Flisiak, A. C. Gadano, E. Gane, W. Halota, A. Hatzakis, C. Henderson, P. Hoffmann, J. Hornell, D. Houlihan, S. Hrusovsky, P. Jarčuška, D. Kershenobich, K. Kostrzewska, P. Kristian, M. Leshno, Y. Lurie, A. Mahomed, N. Mamonova, N. Mendez-Sanchez, J. Mossong, E. Nurmukhametova, P. Nymadawa, M. Oltman, J. Oyunbileg, Ts Oyunsuren, G. Papatheodoridis, N. Pimenov, N. Prabdial-Sing, M. Prins, P. Puri, S. Radke, A. Rakhmanova, H. Razavi, K. Razavi-Shearer, H. W. Reesink, E. Ridruejo, R. Safadi, O. Sagalova, R. Sanduijav, I. Schréter, C. Seguin-Devaux, S. R. Shah, I. Shestakova, A. Shevaldin, O. Shibolet, S. Sokolov, K. Souliotis, C. W. Spearman, T. Staub, E. A. Strebkova, D. Struck, K. Tomasiewicz, L. Undram, A. J. Van Der Meer, D. Van Santen, I. Veldhuijzen, F. G. Villamil, S. Willemse, F. R. Zuure, M. O. Silva, V. Sypsa, E. Gower

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

90 Scopus citations

Abstract

Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.

Original language	English
Pages (from-to)	6-25
Number of pages	20
Journal	Journal of Viral Hepatitis
Volume	22
Issue number	s1
DOIs	https://doi.org/10.1111/jvh.12350
State	Published - 1 Jan 2015
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2014 John Wiley & Sons Ltd.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HCV
diagnosis
disease burden
epidemiology
hepatitis C
incidence
mortality
prevalence
treatment

Access to Document

10.1111/jvh.12350

Cite this

Saraswat, V., Norris, S., De Knegt, R. J., Sanchez Avila, J. F., Sonderup, M., Zuckerman, E., Arkkila, P., Stedman, C., Acharya, S., Aho, I., Anand, A. C., Andersson, M. I., Arendt, V., Baatarkhuu, O., Barclay, K., Ben-Ari, Z., Bergin, C., Bessone, F., Blach, S., ... Gower, E. (2015). Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2. Journal of Viral Hepatitis, 22(s1), 6-25. https://doi.org/10.1111/jvh.12350

@article{ca5ce8dca35d42f186299f5cfcd07ecb,

title = "Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2",

abstract = "Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13\% in the Netherlands to 2.91\% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.",

keywords = "HCV, diagnosis, disease burden, epidemiology, hepatitis C, incidence, mortality, prevalence, treatment",

author = "V. Saraswat and S. Norris and \{De Knegt\}, \{R. J.\} and \{Sanchez Avila\}, \{J. F.\} and M. Sonderup and E. Zuckerman and P. Arkkila and C. Stedman and S. Acharya and I. Aho and Anand, \{A. C.\} and Andersson, \{M. I.\} and V. Arendt and O. Baatarkhuu and K. Barclay and Z. Ben-Ari and C. Bergin and F. Bessone and S. Blach and N. Blokhina and Brunton, \{C. R.\} and G. Choudhuri and V. Chulanov and L. Cisneros and Croes, \{E. A.\} and Dahgwahdorj, \{Y. A.\} and O. Dalgard and Daruich, \{J. R.\} and Dashdorj, \{N. R.\} and D. Davaadorj and \{De Vree\}, M. and C. Estes and R. Flisiak and Gadano, \{A. C.\} and E. Gane and W. Halota and A. Hatzakis and C. Henderson and P. Hoffmann and J. Hornell and D. Houlihan and S. Hrusovsky and P. Jar{\v c}u{\v s}ka and D. Kershenobich and K. Kostrzewska and P. Kristian and M. Leshno and Y. Lurie and A. Mahomed and N. Mamonova and N. Mendez-Sanchez and J. Mossong and E. Nurmukhametova and P. Nymadawa and M. Oltman and J. Oyunbileg and Ts Oyunsuren and G. Papatheodoridis and N. Pimenov and N. Prabdial-Sing and M. Prins and P. Puri and S. Radke and A. Rakhmanova and H. Razavi and K. Razavi-Shearer and Reesink, \{H. W.\} and E. Ridruejo and R. Safadi and O. Sagalova and R. Sanduijav and I. Schr{\'e}ter and C. Seguin-Devaux and Shah, \{S. R.\} and I. Shestakova and A. Shevaldin and O. Shibolet and S. Sokolov and K. Souliotis and Spearman, \{C. W.\} and T. Staub and Strebkova, \{E. A.\} and D. Struck and K. Tomasiewicz and L. Undram and \{Van Der Meer\}, \{A. J.\} and \{Van Santen\}, D. and I. Veldhuijzen and Villamil, \{F. G.\} and S. Willemse and Zuure, \{F. R.\} and Silva, \{M. O.\} and V. Sypsa and E. Gower",

note = "Publisher Copyright: {\textcopyright} 2014 John Wiley \& Sons Ltd.",

year = "2015",

month = jan,

day = "1",

doi = "10.1111/jvh.12350",

language = "אנגלית",

volume = "22",

pages = "6--25",

journal = "Journal of Viral Hepatitis",

issn = "1352-0504",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "s1",

}

Saraswat, V, Norris, S, De Knegt, RJ, Sanchez Avila, JF, Sonderup, M, Zuckerman, E, Arkkila, P, Stedman, C, Acharya, S, Aho, I, Anand, AC, Andersson, MI, Arendt, V, Baatarkhuu, O, Barclay, K, Ben-Ari, Z, Bergin, C, Bessone, F, Blach, S, Blokhina, N, Brunton, CR, Choudhuri, G, Chulanov, V, Cisneros, L, Croes, EA, Dahgwahdorj, YA, Dalgard, O, Daruich, JR, Dashdorj, NR, Davaadorj, D, De Vree, M, Estes, C, Flisiak, R, Gadano, AC, Gane, E, Halota, W, Hatzakis, A, Henderson, C, Hoffmann, P, Hornell, J, Houlihan, D, Hrusovsky, S, Jarčuška, P, Kershenobich, D, Kostrzewska, K, Kristian, P, Leshno, M, Lurie, Y, Mahomed, A, Mamonova, N, Mendez-Sanchez, N, Mossong, J, Nurmukhametova, E, Nymadawa, P, Oltman, M, Oyunbileg, J, Oyunsuren, T, Papatheodoridis, G, Pimenov, N, Prabdial-Sing, N, Prins, M, Puri, P, Radke, S, Rakhmanova, A, Razavi, H, Razavi-Shearer, K, Reesink, HW, Ridruejo, E, Safadi, R, Sagalova, O, Sanduijav, R, Schréter, I, Seguin-Devaux, C, Shah, SR, Shestakova, I, Shevaldin, A, Shibolet, O, Sokolov, S, Souliotis, K, Spearman, CW, Staub, T, Strebkova, EA, Struck, D, Tomasiewicz, K, Undram, L, Van Der Meer, AJ, Van Santen, D, Veldhuijzen, I, Villamil, FG, Willemse, S, Zuure, FR, Silva, MO, Sypsa, V & Gower, E 2015, 'Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2', Journal of Viral Hepatitis, vol. 22, no. s1, pp. 6-25. https://doi.org/10.1111/jvh.12350

TY - JOUR

T1 - Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

AU - Saraswat, V.

AU - Norris, S.

AU - De Knegt, R. J.

AU - Sanchez Avila, J. F.

AU - Sonderup, M.

AU - Zuckerman, E.

AU - Arkkila, P.

AU - Stedman, C.

AU - Acharya, S.

AU - Aho, I.

AU - Anand, A. C.

AU - Andersson, M. I.

AU - Arendt, V.

AU - Baatarkhuu, O.

AU - Barclay, K.

AU - Ben-Ari, Z.

AU - Bergin, C.

AU - Bessone, F.

AU - Blach, S.

AU - Blokhina, N.

AU - Brunton, C. R.

AU - Choudhuri, G.

AU - Chulanov, V.

AU - Cisneros, L.

AU - Croes, E. A.

AU - Dahgwahdorj, Y. A.

AU - Dalgard, O.

AU - Daruich, J. R.

AU - Dashdorj, N. R.

AU - Davaadorj, D.

AU - De Vree, M.

AU - Estes, C.

AU - Flisiak, R.

AU - Gadano, A. C.

AU - Gane, E.

AU - Halota, W.

AU - Hatzakis, A.

AU - Henderson, C.

AU - Hoffmann, P.

AU - Hornell, J.

AU - Houlihan, D.

AU - Hrusovsky, S.

AU - Jarčuška, P.

AU - Kershenobich, D.

AU - Kostrzewska, K.

AU - Kristian, P.

AU - Leshno, M.

AU - Lurie, Y.

AU - Mahomed, A.

AU - Mamonova, N.

AU - Mendez-Sanchez, N.

AU - Mossong, J.

AU - Nurmukhametova, E.

AU - Nymadawa, P.

AU - Oltman, M.

AU - Oyunbileg, J.

AU - Oyunsuren, Ts

AU - Papatheodoridis, G.

AU - Pimenov, N.

AU - Prabdial-Sing, N.

AU - Prins, M.

AU - Puri, P.

AU - Radke, S.

AU - Rakhmanova, A.

AU - Razavi, H.

AU - Razavi-Shearer, K.

AU - Reesink, H. W.

AU - Ridruejo, E.

AU - Safadi, R.

AU - Sagalova, O.

AU - Sanduijav, R.

AU - Schréter, I.

AU - Seguin-Devaux, C.

AU - Shah, S. R.

AU - Shestakova, I.

AU - Shevaldin, A.

AU - Shibolet, O.

AU - Sokolov, S.

AU - Souliotis, K.

AU - Spearman, C. W.

AU - Staub, T.

AU - Strebkova, E. A.

AU - Struck, D.

AU - Tomasiewicz, K.

AU - Undram, L.

AU - Van Der Meer, A. J.

AU - Van Santen, D.

AU - Veldhuijzen, I.

AU - Villamil, F. G.

AU - Willemse, S.

AU - Zuure, F. R.

AU - Silva, M. O.

AU - Sypsa, V.

AU - Gower, E.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.

AB - Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.

KW - HCV

KW - diagnosis

KW - disease burden

KW - epidemiology

KW - hepatitis C

KW - incidence

KW - mortality

KW - prevalence

KW - treatment

UR - https://www.scopus.com/pages/publications/84920274258

U2 - 10.1111/jvh.12350

DO - 10.1111/jvh.12350

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 25560839

AN - SCOPUS:84920274258

SN - 1352-0504

VL - 22

SP - 6

EP - 25

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

IS - s1

ER -

Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this